Nissin Medical Industries Co. Ltd
Nissin Medical Industries Co. Ltd., commonly referred to as Nissin, is a prominent player in the medical equipment industry, headquartered in Japan. Established in 1950, the company has made significant strides in the development and manufacturing of high-quality medical devices, particularly in the field of wheelchairs and mobility aids. With a strong operational presence across Asia and beyond, Nissin is renowned for its innovative approach to enhancing patient mobility and comfort. Their core products, including advanced wheelchairs and rehabilitation equipment, are distinguished by their ergonomic design and cutting-edge technology. Nissin's commitment to quality and user-centric solutions has solidified its market position, making it a trusted name among healthcare professionals and patients alike. The company continues to set benchmarks in the industry, reflecting its dedication to improving the lives of individuals with mobility challenges.
DitchCarbon Score
How does Nissin Medical Industries Co. Ltd's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Motor Vehicle Retail Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Nissin Medical Industries Co. Ltd's score of 26 is higher than 82% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Nissin Medical Industries Co. Ltd's reported carbon emissions
In 2019, Nissin Medical Industries Co. Ltd reported total carbon emissions of approximately 16,252,000 kg CO2e for Scope 1, 14,403,000 kg CO2e for Scope 2, and 2,961,000 kg CO2e for Scope 3. This data highlights the company's significant carbon footprint across all scopes of emissions. Nissin Medical has set ambitious climate commitments, aiming for a 2.7% annual reduction in greenhouse gas emissions, targeting a total reduction of 21.6% by FY2030 compared to FY2022 levels. This commitment applies to both Scope 1 and Scope 2 emissions, indicating a proactive approach to mitigating their environmental impact. The company has demonstrated a consistent focus on reducing emissions over the years, with previous years' data showing emissions of approximately 16,559,000 kg CO2e (2018) and 16,245,000 kg CO2e (2017) for Scope 1, alongside corresponding Scope 2 and Scope 3 figures. These efforts reflect Nissin Medical's dedication to sustainability and climate responsibility within the industry.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2015 | 2016 | 2017 | 2018 | 2019 | |
|---|---|---|---|---|---|
| Scope 1 | 15,988,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 |
| Scope 2 | 12,207,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 |
| Scope 3 | 2,939,000 | 0,000,000 | 0,000,000 | 0,000,000 | 0,000,000 |
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Nissin Medical Industries Co. Ltd is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
